IL125925A0 - Isoquinolines useful as analgesics - Google Patents

Isoquinolines useful as analgesics

Info

Publication number
IL125925A0
IL125925A0 IL12592597A IL12592597A IL125925A0 IL 125925 A0 IL125925 A0 IL 125925A0 IL 12592597 A IL12592597 A IL 12592597A IL 12592597 A IL12592597 A IL 12592597A IL 125925 A0 IL125925 A0 IL 125925A0
Authority
IL
Israel
Prior art keywords
alkyl
hydrogen
aralkyl
aryl
pct
Prior art date
Application number
IL12592597A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL125925A0 publication Critical patent/IL125925A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL12592597A 1996-02-28 1997-02-25 Isoquinolines useful as analgesics IL125925A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600769A SE9600769D0 (sv) 1996-02-28 1996-02-28 Compounds useful as analgesic
PCT/SE1997/000315 WO1997031940A1 (en) 1996-02-28 1997-02-25 Isoquinolines useful as analgesics

Publications (1)

Publication Number Publication Date
IL125925A0 true IL125925A0 (en) 1999-04-11

Family

ID=20401594

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12592597A IL125925A0 (en) 1996-02-28 1997-02-25 Isoquinolines useful as analgesics

Country Status (20)

Country Link
US (1) US6034097A (xx)
EP (1) EP0914332B1 (xx)
JP (1) JP2000506138A (xx)
KR (1) KR19990087322A (xx)
CN (1) CN1211990A (xx)
AT (1) ATE217322T1 (xx)
AU (1) AU722032B2 (xx)
BR (1) BR9707767A (xx)
CA (1) CA2244219A1 (xx)
CZ (1) CZ272098A3 (xx)
DE (1) DE69712490D1 (xx)
EE (1) EE9800266A (xx)
IL (1) IL125925A0 (xx)
IS (1) IS4834A (xx)
NO (1) NO983945L (xx)
NZ (1) NZ331119A (xx)
PL (1) PL328734A1 (xx)
SE (1) SE9600769D0 (xx)
SK (1) SK113498A3 (xx)
WO (1) WO1997031940A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604789D0 (sv) * 1996-12-20 1996-12-20 Astra Ab New Compounds
JP4565747B2 (ja) * 1999-02-04 2010-10-20 エスケー ホルディングス カンパニー リミテッド テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物
IL144583A0 (en) * 2001-07-26 2002-05-23 Peptor Ltd Chimeric protein kinase inhibitors
JP4459629B2 (ja) 2002-04-12 2010-04-28 メルク エンド カムパニー インコーポレーテッド 二環式アミド
IL156429A0 (en) * 2003-06-12 2004-01-04 Peptor Ltd Cell permeable conjugates of peptides for inhibition of protein kinases
CN100503571C (zh) 2006-07-12 2009-06-24 中国药科大学 四氢异喹啉类衍生物、其制备方法及其医药用途
WO2008016913A1 (en) * 2006-07-31 2008-02-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the dmt-tic pharmacophore and methods of use
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
CA2676066C (en) 2007-01-22 2016-06-28 Gtx, Inc. Nuclear receptor binding agents
WO2011104649A1 (en) 2010-02-25 2011-09-01 Pfizer Limited Peptide analogues
WO2014100695A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
PT2935222T (pt) 2012-12-21 2018-12-10 Epizyme Inc Inibidores de prmt5 e seus usos
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
US9745291B2 (en) 2012-12-21 2017-08-29 Epizyme, Inc. PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
JP2016505001A (ja) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
CN103450079B (zh) * 2013-08-14 2015-07-29 中国药科大学 四氢异喹啉羟基衍生物、其制备方法及其医药用途
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof
EP3565543A4 (en) * 2017-01-06 2020-10-14 The Regents of The University of California MU TYPE OPIOID RECEIVER MODULATORS
WO2019195634A1 (en) 2018-04-04 2019-10-10 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto
TW202304869A (zh) 2021-04-05 2023-02-01 美商艾碧奧戴股份有限公司 類鴉片受體調節劑
CN115260096B (zh) * 2022-08-19 2024-04-09 武汉大学 一种基于一氧化碳气体或一氧化碳替代源合成二氢异喹啉酮类化合物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds
CA2118985A1 (en) * 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives

Also Published As

Publication number Publication date
SK113498A3 (en) 1999-02-11
NO983945L (no) 1998-10-06
CZ272098A3 (cs) 1999-03-17
JP2000506138A (ja) 2000-05-23
BR9707767A (pt) 1999-07-27
AU2109097A (en) 1997-09-16
DE69712490D1 (de) 2002-06-13
IS4834A (is) 1998-08-26
AU722032B2 (en) 2000-07-20
CA2244219A1 (en) 1997-09-04
SE9600769D0 (sv) 1996-02-28
EP0914332A1 (en) 1999-05-12
EP0914332B1 (en) 2002-05-08
US6034097A (en) 2000-03-07
CN1211990A (zh) 1999-03-24
NO983945D0 (no) 1998-08-27
PL328734A1 (en) 1999-02-15
KR19990087322A (ko) 1999-12-27
NZ331119A (en) 2000-05-26
EE9800266A (et) 1999-02-15
ATE217322T1 (de) 2002-05-15
WO1997031940A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
IL125925A0 (en) Isoquinolines useful as analgesics
CO5150173A1 (es) Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
NO20023457L (no) Nye piperidinforbindelser og legemidler inneholdende de samme
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
ATE170519T1 (de) Stickstoff enthaltende kondensierte heterocylen
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
DE69330612D1 (de) Neue pyridon carbonsäure-derivate
DE69130326D1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
LV10433A (lv) Panemiens heksahidroazepina atvasinajumu iegusanai
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
ATE170862T1 (de) 5-ht3 pyrrolopyrazinderivate
CA2206168A1 (en) Organic peroxide stabilization with .alpha.-hydroxyalkyl peroxides
NO991835L (no) Prosess
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
EP1403250A4 (en) BIS DERIVATIVE (5-ARYL-2-PYRIDYL)
MY147944A (en) Substituted 1,2,4-trioxanes as antimalarial agents and a process of producing the substituted 1,2,4-trioxanes
AU2002339174A8 (en) Light emitting device and compounds for use therein
MX9708155A (es) Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos.
TWI256383B (en) Anthraquinone compound
MX9703724A (es) Antagonistas de bradiquinina heterociclicos con contenido en azufre, procedimiento para su preparacion y su empleo.
TH16651A (xx)
CO4480104A1 (es) Derivados de la bencilpiperidina